Bahrain - Re-Export of Heparin for Therapeutic Use
At $712.55 in 2017, the country was number 10 among other countries in Re-Export of Heparin for Therapeutic Use. United States topped the ranking with $4,598,060.57 in 2019, a decrease of 5.2% versus 2018. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +141.8% per year, while United States witnessed the worst performance at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2017 | 712.55 |
| 2016 | 653.93 |
| 2015 | 4,347.07 |
| 2014 | 1,863.00 |
| 2013 |
Download all data from 2005 to 2017
How does Bahrain rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data | |
| 9 |
#9
Moldova
|
2,072.00 | 2017 | +67.6 % | NA | View data | |
| 10 |
#10
Bahrain
|
712.55 | 2017 | +9.0 % | NA | View data | |